NZ225342A - 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyhept-6-enoic or 3,5-dihydroxyheptanoic acid derivatives, their corresponding delta-lactones, pharmaceutical compositions thereof and intermediate compounds - Google Patents
7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyhept-6-enoic or 3,5-dihydroxyheptanoic acid derivatives, their corresponding delta-lactones, pharmaceutical compositions thereof and intermediate compoundsInfo
- Publication number
- NZ225342A NZ225342A NZ225342A NZ22534288A NZ225342A NZ 225342 A NZ225342 A NZ 225342A NZ 225342 A NZ225342 A NZ 225342A NZ 22534288 A NZ22534288 A NZ 22534288A NZ 225342 A NZ225342 A NZ 225342A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- phenyl
- isopropyl
- methyl
- denotes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873722806 DE3722806A1 (de) | 1987-07-10 | 1987-07-10 | 7-(1h-pyrrol-3-yl)-substituierte 3,5-dihydroxy-hept-6-ensaeuren, 7-(1h-pyrrol-3-yl)-substituierte 3,5-dihydroxy-heptansaeuren, ihre entsprechenden (delta)-lactone und salze, verfahren zu ihrer herstellung ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ225342A true NZ225342A (en) | 1991-03-26 |
Family
ID=6331291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ225342A NZ225342A (en) | 1987-07-10 | 1988-07-08 | 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyhept-6-enoic or 3,5-dihydroxyheptanoic acid derivatives, their corresponding delta-lactones, pharmaceutical compositions thereof and intermediate compounds |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5055484A (enExample) |
| EP (1) | EP0300249B1 (enExample) |
| JP (1) | JPS6434959A (enExample) |
| KR (1) | KR890002135A (enExample) |
| AT (1) | ATE85324T1 (enExample) |
| AU (1) | AU1888088A (enExample) |
| DE (2) | DE3722806A1 (enExample) |
| DK (1) | DK384288A (enExample) |
| ES (1) | ES2043736T3 (enExample) |
| FI (1) | FI883247A7 (enExample) |
| GR (1) | GR3007611T3 (enExample) |
| HU (1) | HU208672B (enExample) |
| IE (1) | IE63205B1 (enExample) |
| IL (1) | IL87036A0 (enExample) |
| NO (1) | NO883072L (enExample) |
| NZ (1) | NZ225342A (enExample) |
| PH (1) | PH26375A (enExample) |
| PT (1) | PT87927B (enExample) |
| ZA (1) | ZA884918B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3826814A1 (de) * | 1988-08-06 | 1990-02-08 | Hoechst Ag | Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
| FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| IT1237793B (it) * | 1989-12-21 | 1993-06-17 | Zambon Spa | Composti attivi come inibitori dell'enzima hmg-coa reduttasi |
| US5128366A (en) * | 1990-07-05 | 1992-07-07 | Shinogi & Co., Ltd. | Pyrrole derivatives |
| DE4243279A1 (de) * | 1992-12-21 | 1994-06-23 | Bayer Ag | Substituierte Triole |
| US7250444B2 (en) * | 2003-08-11 | 2007-07-31 | Pfizer Inc. | Pyrrole-based HMG-CoA reductase inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3928380A (en) * | 1973-03-29 | 1975-12-23 | Sterling Drug Inc | 1,1{40 -Spirobis(cyclopenta-{8 4,5-c{9 pyrroles) |
| US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
| KR900001212B1 (ko) * | 1985-10-25 | 1990-02-28 | 산도즈 파마슈티칼스 코오포레이숀 | 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도 |
| US4851427A (en) * | 1985-10-25 | 1989-07-25 | Sandoz Pharm. Corp. | Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use |
| US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
| NO881411L (no) * | 1987-04-14 | 1988-10-17 | Bayer Ag | Substituerte pyrroler. |
-
1987
- 1987-07-10 DE DE19873722806 patent/DE3722806A1/de not_active Withdrawn
-
1988
- 1988-07-01 EP EP88110533A patent/EP0300249B1/de not_active Expired - Lifetime
- 1988-07-01 ES ES88110533T patent/ES2043736T3/es not_active Expired - Lifetime
- 1988-07-01 AT AT88110533T patent/ATE85324T1/de not_active IP Right Cessation
- 1988-07-01 DE DE8888110533T patent/DE3878067D1/de not_active Expired - Fee Related
- 1988-07-07 FI FI883247A patent/FI883247A7/fi not_active Application Discontinuation
- 1988-07-07 PT PT87927A patent/PT87927B/pt not_active IP Right Cessation
- 1988-07-08 PH PH37199A patent/PH26375A/en unknown
- 1988-07-08 DK DK384288A patent/DK384288A/da not_active Application Discontinuation
- 1988-07-08 AU AU18880/88A patent/AU1888088A/en not_active Abandoned
- 1988-07-08 US US07/216,423 patent/US5055484A/en not_active Expired - Fee Related
- 1988-07-08 ZA ZA884918A patent/ZA884918B/xx unknown
- 1988-07-08 NO NO88883072A patent/NO883072L/no unknown
- 1988-07-08 HU HU883600A patent/HU208672B/hu not_active IP Right Cessation
- 1988-07-08 NZ NZ225342A patent/NZ225342A/en unknown
- 1988-07-08 JP JP63169159A patent/JPS6434959A/ja active Pending
- 1988-07-08 IE IE209788A patent/IE63205B1/en not_active IP Right Cessation
- 1988-07-08 IL IL87036A patent/IL87036A0/xx unknown
- 1988-07-09 KR KR1019880008546A patent/KR890002135A/ko not_active Withdrawn
-
1993
- 1993-04-09 GR GR930400426T patent/GR3007611T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI883247A7 (fi) | 1989-01-11 |
| AU1888088A (en) | 1989-01-12 |
| IE63205B1 (en) | 1995-04-05 |
| JPS6434959A (en) | 1989-02-06 |
| ES2043736T3 (es) | 1994-01-01 |
| US5055484A (en) | 1991-10-08 |
| DK384288D0 (da) | 1988-07-08 |
| FI883247A0 (fi) | 1988-07-07 |
| HUT48580A (en) | 1989-06-28 |
| IE882097L (en) | 1989-01-10 |
| HU208672B (en) | 1993-12-28 |
| DK384288A (da) | 1989-01-11 |
| KR890002135A (ko) | 1989-04-08 |
| IL87036A0 (en) | 1988-12-30 |
| DE3878067D1 (de) | 1993-03-18 |
| PT87927A (pt) | 1989-06-30 |
| GR3007611T3 (enExample) | 1993-08-31 |
| EP0300249B1 (de) | 1993-02-03 |
| PH26375A (en) | 1992-06-01 |
| NO883072L (no) | 1989-01-11 |
| ATE85324T1 (de) | 1993-02-15 |
| EP0300249A1 (de) | 1989-01-25 |
| ZA884918B (en) | 1989-01-18 |
| DE3722806A1 (de) | 1989-01-19 |
| NO883072D0 (no) | 1988-07-08 |
| PT87927B (pt) | 1995-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0142880B1 (ko) | 3,5-디하이드록시헵트-6-인산의 7-치환된 유도체, 이의 제조방법 및 이를 포함하는 약제학적 생성물 | |
| KR960009434B1 (ko) | 3-데메틸메발론산 유도체, 이의 제조방법 및 중간체 | |
| AU636122B2 (en) | Process for the preparation of 7-substituted-hept-6-enoic and-heptanoic acids and derivatives | |
| Jendralla et al. | Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3, 5-dihydroxyhept-6 (E)-enoic (-heptanoic) acids | |
| CA1328268C (en) | Antihypercholesterolemic tetrazole compounds | |
| KR100978970B1 (ko) | Ｈｍｇ-ｃｏａ 환원효소 저해 메발론산 유도체의 제조방법 | |
| AU612449B2 (en) | New 3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as pharmaceuticals, pharmaceutical products and intermediates | |
| KR20040081161A (ko) | ＨＭＧ-ＣｏＡ 환원효소 억제제의 제조 방법 | |
| US4085222A (en) | Pharmaceutical compositions containing 1,3-dioxanes | |
| EP0312269B1 (en) | 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents | |
| NZ225342A (en) | 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyhept-6-enoic or 3,5-dihydroxyheptanoic acid derivatives, their corresponding delta-lactones, pharmaceutical compositions thereof and intermediate compounds | |
| US5032590A (en) | Substituted hydroxylamines | |
| US4829081A (en) | Analogs of mevalonolactone and derivatives thereof | |
| AU7212700A (en) | Process for preparing 1,4-dihydropyridine compounds | |
| US4751235A (en) | Anti-atherosclerotic indolizine derivatives | |
| US4927851A (en) | Analogs of mevalonolactone and derivatives thereof | |
| IE63491B1 (en) | New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates | |
| HU195799B (en) | Process for producing pharmaceutical compositions containing 3-desmethyl-mevalonic acid derivatives and process for producing the active agents | |
| EP0434070B1 (en) | Pyrrolealdehyde derivative | |
| US4937255A (en) | Disubstituted pyrroles | |
| US5248830A (en) | Enantioselective preparation of acetylenic or olefinic substituted cycloalkenyl dihydroxybutyrates and 4-hydroxy-tetrahydro-pyran-2-ones | |
| CH629741A5 (fr) | Arylenedioxy-bis-dicetones, leur preparation et leur utilisation comme medicaments. | |
| US5952376A (en) | Trienyl compounds | |
| WO1992014692A1 (en) | Enantioselective preparation of acetylenic or olefinic substituted cycloalkenyl dihydroxybutyrates and 4-hydroxy-tetrahydropyran-2-ones | |
| Shafiee et al. | Syntheses of 2‐(2‐arylethyl)‐1‐methylimidazoles |